Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis

Slide: 20 of 37

Intermediate End Points and Health Outcomes in rhGH-Treated Patients With CF (2)

This slide summarizes the studies that met the inclusion criteria for the CER. These studies used regression analyses to test the linkages between intermediate and long-term health outcomes.

Thirty-four studies evaluated the relationship between intermediate outcomes and mortality. Sixteen studies evaluated the relationship between intermediate outcomes and HRQoL. Children, adolescents and adults were evaluated in the included studies.